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Abstract
 
The recruitment of activated T cell subsets to sites of effector immune responses is mediated by
homing receptors induced upon activation in secondary lymphoid tissue. Using an adoptive
transfer model, the intestinal recruitment of CD4
 
 
 
 T cells activated with intraperitoneal anti-
gen in complete Freund’s adjuvant was examined. The data demonstrate that activated CD4
 
 
 
T cells recruited to intestinal Peyer’s patches (PP) and lamina propria (LP) up-regulate func-
tional P-selectin glycoprotein ligand 1 (PSGL-1). Blockade of IL-12 inhibited functional
PSGL-1 expression and reduced PP and LP CD4
 
 
 
 T cell recruitment by 
 
 
 
40%. P-Selectin
blockade reduced LP recruitment of activated cells by 56% without affecting PP recruitment.
Studies of mice examined 3 d after adoptive transfer of differentiated T cell subsets revealed
that Th1 but not Th2 cells were recruited to small intestine PP and LP. Mucosal addressin cell
adhesion molecule blockade reduced Th1 recruitment to PP by 90% and to LP by 
 
 
 
72%,
whereas P-selectin blockade reduced Th1 recruitment to PP by 18% and Th1 recruitment to
LP by 84%. These data suggest that IL-12–induced functional PSGL-1 expression is a major
determinant for the recruitment of Th1 effector cells to noninflamed as well as inflamed intestine.
Key words: memory T cells • lamina propria • small intestine • interleukin-12 • leukocyte 
migration
 
Introduction
 
The participation of effector T cells in intestinal nonlym-
phoid tissue is critical for mucosal host defense. CD4
 
 
 
 lym-
 
phocytes that populate the intestinal lamina propria (LP)
 
*
 
are comprised of previously activated, memory-like T cells
 
that make high levels of effector cytokine (e.g., IFN-
 
 
 
, IL-4,
or IL-10) but not IL-2 (1–3). As naive T cells do not typi-
cally migrate to the LP, effector cells must be recruited after
activation elsewhere. Leukocyte recruitment involves a
multistep process that includes selectin-mediated rolling
and integrin-mediated attachment to endothelial surfaces.
Attachment of 
 
 
 
4
 
 
 
7 integrin to mucosal addressin cell ad-
hesion molecule (MAdCAM)-1 is essential for optimal re-
cruitment of activated T cells into intestinal lymphoid
Peyer’s patches (PP) structures and nonlymphoid LP (4).
Papers from Lefrancois and colleagues suggest that for
CD8
 
 
 
 T cells, an 
 
 
 
4
 
 
 
7-independent pathway of LP re-
cruitment exists (5), and that 
 
 
 
2 integrins (LFA-1) play an
important role in intestinal LP and PP T cell recruitment
 
(6). However, there are few papers that address the molecu-
lar mechanisms of selectin binding in migration of activated
CD4
 
 
 
 T cells to the LP.
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Abbreviations used in this paper:
 
 APC, allophycocyanin; C2GlcNAcT-I,
core 2 
 
  
 
1,6-
 
N
 
-acetylglucosaminyl transferase I; Fuc-T VII, fucosyl-
transferase VII; LP, lamina propria; MAdCAM, mucosal addressin cell ad-
hesion molecule; MLN, mesenteric LN; PLN, peripheral LN; PP, Peyer’s
patches; PSGL-1, P-selectin glycoprotein ligand 1.T
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P-Selectin Ligand in Intestinal Recruitment of Type 1 Helper T Cells
 
Functional ligands for E- and P-selectin on Th1 cells
mediate recruitment to nonlymphoid tissue in inflamed
joints, skin, and peritoneum (7–11). Expression of func-
tional P-selectin glycoprotein ligand (PSGL)-1 is controlled
through posttranslational activity of the enzymes, core 2
 
  
 
1,6-
 
N-
 
acetylglucosaminyl transferase I (C2GlcNAcT-I)
and 
 
 
 
-3 fucosyltransferase VII (Fuc-T VII; references 12–
15). Expression of Fuc-T VII and C2GlcNAcT-I are en-
hanced through activity of the Th1-polarizing cytokine,
IL-12 (13, 14, 16). As the LP is a major site for Th1 effec-
tor responses, we postulated that T cell activation in the
presence of IL-12 would promote Th1 recruitment to the
LP through selective expression of functional PSGL-1.
In this paper, we analyze the role of functional PSGL-1
in CD4
 
 
 
 T cell recruitment to the LP using antigen-spe-
cific adoptive transfer mice. We find a substantial reduction
in recruitment of in vivo–activated cells to the LP in anti–
IL-12 or anti–P-selectin–treated mice, and a virtual absence
of LP recruitment in anti–P-selectin–treated mice given
differentiated Th1 cells. These data assign important roles
for IL-12 and functional PSGL-1 in the migration of acti-
vated T cells to nonlymphoid tissue in the intestine, and
suggest that P-selectin and functional PSGL-1 are major
determinants of Th1 recruitment to the LP.
 
Materials and Methods
 
Mice.
 
BALB/c mice were obtained from The National Can-
cer Institute. DO11.10 mice carrying a transgenic TCR specific
for OVA
 
323–339
 
 peptide plus I-A
 
d
 
 (obtained from D. Loh, Hoff-
mann-LaRoche, Nutley, NJ) were backcrossed to RC17, BALB/c
 
RAG-1
 
 knockout mice (
 
RAG-1
 
 
 
/
 
 
 
) from R. Coffman (DNAX
Research Institute, Palo Alto, CA). All mice were bred and main-
tained in the specific pathogen-free facility at the Lakeside Vet-
eran’s Administration Medical Science Building or at Northwest-
ern University Feinberg School of Medicine in accordance with
guidelines of the Northwestern University Animal Care and Us-
age committee.
 
Cell Isolation.
 
Spleen, mesenteric LN (MLN), or pooled pe-
ripheral LN (PLN; brachial, axillary, and inguinal) from individ-
ual mice were mechanically dissociated, respectively, and RBCs
were lysed with ACK lysis buffer. Cell suspensions were washed
and stored in DMEM containing 5% FBS on ice until used. Cells
from LP and PP were isolated as described previously (3). In
brief, small intestines were removed and flushed with ice-cold
PBS to remove fecal contents. PP were excised and kept on ice.
The intestine was opened longitudinally and minced into 1-cm
pieces. The mucosal pieces and PP were digested twice for 30
min at 37
 
 
 
C with 5 mM EDTA and 10% FCS (GIBCO BRL) in
PBS. After each digestion, pieces were washed with cold PBS and
supernatants were discarded. The remaining tissue was digested
for five 30-min intervals in a buffer containing 100 U/ml collage-
nase (Sigma-Aldrich), 25 mM Hepes (GIBCO BRL), 7 mM
CaCl
 
2
 
 (Sigma-Aldrich), and 20% FCS in DMEM (GIBCO
BRL). After each 30-min interval, the cells released were centri-
fuged, washed, and stored in 5% DMEM on ice, and the mucosal
pieces were replaced in the collagenase buffer. After the third in-
terval, the digestion buffer was supplemented with an additional
100 U/ml collagenase and 2.5 ml FCS for two additional 30-min
intervals. After digestion, the cells were kept overnight on ice in
 
5% DMEM. The next day, the cells were incubated for 1 h at
37
 
 
 
C. Viable cells were obtained by suspending the cells in 0.3
 
 
 
g/ml dithiothreitol (GIBCO BRL) in DMEM and centrifuging
them over Nycoprep 1.077 (Accurate Chemical).
 
T Cell Enrichment and Generation of Th1 and Th2 Cell Lines.
 
Freshly isolated spleen and MLN cells from DO11.10 
 
 
 
 
 
RAG-
1
 
 
 
/
 
 
 
 mice were resuspended in column buffer and passed
through a T cell enrichment column (R&D Systems) according
to the manufacturer’s instructions. To generate Th1 and Th2
cells, the enriched T cells were cultured with 1 
 
 
 
g/ml immobi-
lized anti-CD3 and anti-CD28 (BD Biosciences) in a 24-well
plate (Costar) at 2 
 
 
 
 10
 
6
 
 cells/well for 2 d, followed by 6 d in a
FALCON tissue culture flask (Becton Dickinson) at 2 
 
 
 
 10
 
6
 
cells/ml, in the presence of 10 ng/ml IL-12 (BD Biosciences) and
10 
 
 
 
g/ml anti–IL-4 (a gift from C. Reynolds, National Institutes
of Health, Bethesda, MD) for Th1 cell differentiation, or IL-4
(R&D Systems) and anti–IFN-
 
 
 
 (XMG-1.2, a gift from S. Hurst,
DNAX Corp, Palo Alto, CA) for Th2 cell differentiation. Cells
were harvested on the eighth day of the culture, and prepared for
adoptive cell transfer.
 
Adoptive Cell Transfer and Ag Challenge.
 
The enriched naive
DO11.10 T cells, Th1 cells, or Th2 cells were passed through
Nitex filters to remove any debris, washed 3–4 times with PBS,
and diluted with PBS in the appropriate concentration. Approxi-
mately 5 
 
 
 
 10
 
6
 
 T cells were given by i.v. tail vein injection (200
 
 
 
l) to BALB/c recipients. Adoptive transferred BALB/c mice
were challenged i.p. with 150 
 
 
 
g OVA
 
323–339
 
 (University of
North Carolina) in CFA (Sigma-Aldrich), or PBS/CFA as a con-
trol. In some cases, mice were treated i.p. with 150 
 
 
 
g OVA
 
323–339
 
and 100 
 
 
 
g LPS (
 
Escherichia coli
 
 serotype 055:B5; Sigma-Aldrich)
as described previously (17).
 
Blocking Antibodies.
 
Anti–IL-12 mAb was purified from su-
pernatant from clone 17.8 obtained from G. Trinchieri (Scher-
ing-Plough Research Institute, Dardilly, France; reference 18).
Hermes-1 rat isotype control hybridoma was obtained at the De-
velopmental Studies Hybridoma Bank. MECA-367 (anti-MAd-
CAM), 17.8, and Hermes-1 hybridomas were grown in a biore-
actor (Heraeus) or as ascites and antibody purified with the
Gammabind plus protein G column (Amersham Biosciences).
The mouse E-selectin blocking mAb (9A9E3.F10, a rat IgG2b)
and the mouse P-selectin blocking mAb (RMP-1, a mouse
IgG2a) were gifts from A. Issekutz (Dalhousie University, Hali-
fax, Nova Scotia, Canada; references 19, 20). Isotype control
mouse IgG2a (clone G155–178) and rat IgG1 control (R3–34)
were purchased from BD Biosciences. Purified antibodies for in
vivo use were checked for endotoxin by the limulus assay (Asso-
ciates of Cape Cod) and found to be 
 
 
 
1 EU/ml. For mAb treat-
ment, 2 mg anti–IL-12 or control mAb was given i.p. 2 h before
Ag challenge. 0.2 mg anti-MAdCAM or control Ab was given
daily in the indicated experiments. The anti–P-selectin, anti–
E-selectin, or control mAbs was given 0.3 mg i.p. 2 h before Ag
challenge, followed by 0.2 mg i.p on the third and fifth days after
Ag challenge. In addition, a rat anti–mouse P-selectin mAb
(RB40.34, rat IgG1) (a gift from K. Ley, University of Virginia,
Charlottesville, VA) was used to confirm the result (see Fig. 2).
 
FACS
 
®
 
 Analysis.
 
Adoptive transferred BALB/c mice were
killed three or seven days after Ag challenge. Cells from the
spleen, MLN, PLNs, LP, and PP were freshly isolated as de-
scribed previously. For three or four color analysis, cells were
stained with FITC-, PE-, and allophycocyanin (APC)-conju-
gated mAbs for CD4, KJ1–26.1, and Thy-1, or isotype-matched
mAbs (all were obtained from BD Biosciences unless other-
wise indicated). In some experiments, the cells were stained forT
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L-selectin, 
 
 
 
4
 
 
 
7, or functional PSGL-1 expression in addition to
CD4 and KJ1.26. Functional PSGL-1 expression was deter-
mined by P-selectin binding using a murine P-selectin/human
IgM chimeric Ab (P-selectin–Ig; a gift from L. Stoolman, Uni-
versity of Michigan, Ann Arbor, MI), followed by APC-labeled
anti–human IgM (Jackson ImmunoResearch Laboratories) as de-
scribed previously (16). Parallel staining with control chimeric
CD45-Ig or P-selectin–Ig in presence of EDTA served as con-
trols. Nonviable cells were excluded from analysis on the basis of
propidium iodide staining. Data were collected and analyzed us-
ing a FACSCalibur™ flow cytometer and CELLQuest™ soft-
ware (Becton Dickinson).
 
Statistical Analyses.
 
Statistical comparisons of cell recruitment
in spleen, MLN, PP, and LP between treated groups were as-
sessed using a one-tailed Student’s 
 
t
 
 test (Microsoft
 
®
 
 Excel 2000).
P values 
 
 
 
0.05 were considered significant.
 
Online Supplemental Material. 
 
The role of E-selectin in re-
cruitment of activated T cells to the intestine is explored here.
BALB/c mice, adoptively transferred with DO11.10 T cells,
were pretreated with control or anti–E-selectin mAbs and chal-
lenged with i.p. OVA/CFA. Fig. S1 shows the proportion of
CD4
 
+
 
 DO11.10 T cells in spleen (SP), MLN, PP, and LP,
and the yields of DO11.10 T cells recovered are shown. Fig.
S1 is available at http://www.jem.org/cgi/content/full/jem.
20020691/DC1.
 
Results
 
IL-12 Regulates Activation-induced T Cell Migration to the
Intestine. 
 
To address the role of IL-12 and functional
PSGL-1 in recruitment of activated CD4
 
 
 
 T cells to the
LP, we used an in vivo model for activation-induced intes-
tinal T cell migration. Using adoptive transfer mice, we
found that i.p. injection of OVA
 
323–339
 
 in CFA (OVA/
CFA) induces expansion of DO11.10 T cells in spleen and
MLN followed by recruitment to PP and LP, as detected
5–7 d after priming. It has been suggested that IL-12 directs
migration of activated Th1 cells to nonlymphoid tissue
through up-regulation of surface homing receptors such as
functional PSGL-1 (7, 11). To examine the role of IL-12 in
activation-induced intestinal migration, adoptive transfer
mice were treated with anti–IL-12 or control mAb be-
fore  immunization. Analysis of cytokine production by
DO11.10 T cells indicate that anti–IL-12 effectively
blocked induction of IFN-
 
 
 
 production by Ag-stimulated
cells isolated 7 d after i.p. OVA/CFA (unpublished data).
Data in Fig. 1 (A and B) indicate that IL-12 blockade re-
duced DO11.10 T cells in LP and PP. Analysis of the per-
cent change in DO11.10 cell yield (Fig. 1 C) reveals that
anti–IL-12 reduced numbers of DO11.10 T cells in LP by
47 
 
 
 
 8% (P 
 
  
 
0.03) and in PP by 45 
 
 
 
 7% (P 
 
  
 
0.04). In-
terestingly, DO11.10 T cell numbers in the spleen and
MLN increased slightly, suggesting that activated T cells
redistributed to these sites when entry to peripheral non-
lymphoid sites was inhibited. Annexin V staining revealed
that levels of DO11.10 T cell apoptosis were not affected
by anti–IL-12 (unpublished data). Data in Fig. 1 D show
that within 72 h of activation with i.p. OVA/CFA,
DO11.10 T cells in draining MLN up-regulated both
 
 
 
4
 
 
 
7 and functional PSGL-1 expressions. Although 89%
 
of DO11.10 T cells expressed 
 
 
 
4
 
 
 
7, 69% of cells expressed
functional PSGL-1. A substantial (66%) subset of MLN
DO11.10 T cells expressed both homing receptors, indicat-
ing that nearly all (95%) cells that up-regulated functional
PSGL-1 increased 
 
 
 
4
 
 
 
7 expression. By comparison, 9% of
DO11.10 cells isolated from PLN (inguinal, axillary, and
brachial) expressed functional PSGL-1 in combination with
 
 
 
4
 
 
 
7 (Fig. 2 B). Data in Fig. 1 E show that 7 d after i.p.
OVA/CFA, 59% of DO11.10 cells recruited to the LP ex-
pressed functional PSGL-1, whereas 18 and 8% in the PP
and spleen bound P-selectin–Ig, respectively. These data
are consistent with results in normal BALB/c and C57BL/6
B6 mice, where 53–58% of endogenous LP CD4
 
 
 
 T cells
were found to bind P-selectin–Ig (unpublished data). To-
gether, these data suggest that IL-12 plays a role in the in-
testinal recruitment of activated CD4
 
 
 
 T cells.
To directly address the effect of IL-12 neutralization on
surface expression of tissue homing receptors, cells were
isolated from control and anti–IL-12 mAb–treated mice
and analyzed by flow cytometry. Consistent with previous
papers (7, 11), IL-12 neutralization reduced functional
PSGL-1 expression by MLN DO11.10 cells by 
 
 
 
50%.
Data presented in Fig. 2 A indicate that IL-12 does not af-
fect 
 
 
 
4
 
 
 
7 up-regulation or L-selectin shedding. Interest-
ingly, we detected a subset of MLN DO11.10 cells (15%)
that expressed 
 
 
 
4
 
 
 
7 and functional PSGL-1 when mice
were stimulated with i.p. LPS and OVA
 
323–339
 
 peptide for
48 h. These results suggest that conditions that promote
Th1 differentiation (other than CFA) also induce coexpres-
sion of functional PSGL-1 and 
 
 
 
4
 
 
 
7 (Fig. 2 C). Together,
the data in Fig. 1 D along with data in Fig. 2 (B and C)
suggest that most cells in MLN and PLN up-regulate func-
tional PSGL-1 upon activation with “Th1-promoting”
CFA or LPS.
 
The Role of PSGL-1 in Recruitment of Activated CD4
 
 
 
 T
Cells to the LP and PP. 
 
To directly test whether P-selec-
tin and PSGL-1 were involved in activation-induced intes-
tinal T cell migration, mice were treated with blocking
mAb directed against tissue P-selectin (19). Data in Fig. 3
(A–C) suggest that P-selectin blockade reduced DO11.10
CD4
 
 
 
 T cell recruitment to the LP while increasing cells in
the spleen and MLN. Analysis of the percent change in
DO11.10 T cell yields indicate that anti–P-selectin mAb
treatment increased numbers of DO11.10 T cells in the
spleen and MLN by 14 
 
 
 
 3% and 8   3%, respectively,
while decreasing DO11.10 cells in PP by 6   2% (Fig. 3
C). In comparison, data show that anti–P-selectin Ab re-
duced LP DO11.10 cell numbers by 59   3% (P   0.001).
Results in mice treated with anti–E-selectin mAb failed to
show significant effects of E-selectin blockade in this model
(Fig. S1 available at http://www.jem.org/cgi/content/full/
jem.20020691/DC1). Together, these data suggest that a
substantial number of activated T cells utilize P-selectin for
intestinal LP migration.
The Role of P-Selectin in the Selective Migration of Th1 Cells
to the PP and LP.  To directly address the role of P-selec-
tin in the intestinal recruitment of differentiated T cell sub-
sets, we studied the influence of anti–P-selectin mAb onT
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localization of Th1 and Th2 cells to PP and LP. Differenti-
ated Th1 cells were generated by activating naive cells with
immobilized anti-CD3 and anti-CD28 mAbs followed by
culturing for 7 d in IL-12 and anti–IL-4 or IL-4 and anti–
IFN-  as published previously (14). Data from mice exam-
ined 72 h after cell transfer suggest that differentiated Th1
DO11.10 cells were recruited to the small bowel LP in rel-
atively high numbers compared with Th2 cells (Fig. 4, A
and C). To determine whether accumulation of Th1 cells
in the intestine was due to recruitment versus local expan-
sion, mice were treated with anti-MAdCAM mAb (21).
Consistent with previous findings, MAdCAM blockade re-
duced Th1 recruitment to PP by 82   2% (P   0.008) and
to the LP by 71   7% (P   0.03) (Fig. 4, A and B). Results
in anti–P-selectin mAb-treated mice indicate that P-selec-
tin blockade reduced Th1 PP recruitment by 18   4%
Figure 1. IL-12 regulates activa-
tion-induced T cell migration to the
intestine. Naive CD4  KJ1.26  T
cells were transferred to BALB/c
mice given control mAb (C mAb) or anti–IL-12 mAb. After 24 h, the mice were
challenged with i.p. PBS/CFA or OVA323–339/CFA. The mice were killed and ana-
lyzed on 3 or 7 d after Ag challenge. (A) Cells from spleen, MLN, LP, and PP were
isolated 7 d after Ag challenge and stained with KJ1–26.1–PE, anti–CD4 mAb-FITC,
and anti–Thy-1 APC (for gating). Numbers shown in top right quadrants indicate the
percentages of CD4  KJ1–26.1  cells out of total CD4  T cells in each compartment.
(B) Yields (mean   SEM) of the transferred CD4  KJ1.26  cells recovered in SP,
MLN, PP, and LP from each indicated group (n   3/group) at 7 d are shown. (C)
Comparison of percentage changes by anti–IL-12 mAb of CD4  KJ1–26.1  cell yield
(mean   SEM) relative to Ag-challenged, control mAb-treated controls at 7 d. (D)
 4 7 and functional PSGL-1 expression on DO11.10 cells. Cells were isolated from
MLN of adoptive transferred mice 3 d after Ag challenge and stained with anti- 4 7
and P-selectin–Ig (Materials and Methods). Cells were gated on the basis of CD4 and
KJ1–26.1 staining. (E) P-Selectin–Ig binding (darker line) on SP, PP, and LP 7 d after
Ag challenge, showing that functional PSGL-1  CD4  KJ1–26.1  cells were prefer-
entially recruited to the intestine. Levels of staining for the chimeric control are
shown as dotted lines (identical to results of P-selectin–Ig in the presence of EDTA).
Indicated is the percentage of functional PSGL-1  cells above background. Data are
representative of three independent experiments with similar results. *, P   0.04.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
373 Haddad et al.
(P   0.02) and Th1 LP recruitment by  83   2% (P  
0.0003). Together, these data suggest that P-selectin is a
major determinant of Th1 recruitment to extralymphoid
sites within the intestinal LP.
Discussion
We present new information regarding the role of IL-12
and PSGL-1 in generating effector immune responses in
the intestine. Administration of i.p. Ag in CFA induced
migration of activated effector T cells to the intestinal PP
and LP. In this model, DO11.10 cells are initially activated
in the MLN and spleen, where they expand and up-regu-
late functional PSGL-1 (Fig. 1 D). Findings in anti–IL-12–
treated mice suggest that PSGL-1 is not required for
DO11.10 T cell activation or peripheral expansion. These
data are consistent with findings by Xie et al. (7), who
noted a similar lack of effect of anti–P-selectin and E-selec-
tin mAbs in recruitment of activated T cells to spleen. It is
possible that recruitment of cells to MLN as well as spleen
may be mediated by alternate homing receptors such as
L-selectin or LFA-1. By 4 d, cells begin to appear in the in-
testinal LP where they express PSGL-1 (Fig. 1 E). The no-
tion that functional PSGL-1 bound P-selectin during
recruitment to the intestine was tested by injecting anti–
P-selectin mAb. Anti–P-selectin mAb significantly reduced
intestinal LP recruitment of DO11.10 T cells activated
with i.p. OVA/CFA (Fig. 3, A–C) and nearly abrogated
recruitment of differentiated Th1 cells to the LP (Fig. 4, A
and B). The relatively modest effect of P-selectin blockade
on PP recruitment is consistent with data from Kunkel et
al. (22), which suggested that P-selectin plays a minor role
in recruitment of effector T cell recruitment to PP tissue.
In contrast, the effect we observed for Th1 cell recruitment
to the LP was pronounced in all the studies performed,
suggesting that this pathway is an important means for re-
cruiting Th1 effector cells to this compartment. Based on
these data, we hypothesize that effects of IL-12 combine
with TCR signaling to induce functional differentiation
and expression of homing receptors needed for recruitment
of effector T cells to sites of mucosal immune responses
within the intestine.
The pathway described here provides a means for gener-
ating mucosal T cell responses to enteric antigen presented
in draining LNs. The pathway permits the induction of im-
mune responses to enteric Ag normally contained in mu-
cosal tissue. Data from Huang et al. support the notion that
mucosal dendritic cells carry enteric pathogen-derived anti-
gen to MLNs, where they produce IL-12 and activate na-
ive T cells (23). Given our findings, we suspect that IL-12
Figure 2. Anti–IL-12 inhibits P-selectin–Ig binding
on activated T cells in MLN without effecting expres-
sion of homing receptors,  4 7, or L-selectin. (A)
BALB/c mice pretreated with control mAb (C mAb)
or anti–IL-12 were adoptively transferred with CD4 
KJ1–26.1  T cells and challenged with i.p. OVA323–339/
CFA. MLN cells were isolated from the mice 7d after
Ag challenge and stained for P-selectin–Ig,  4 7, or
L-selectin. Histograms of cells gated on the basis of
CD4 and KJ1–26.1 staining are shown. Levels of con-
trol chimeric CD45-Ig staining are shown as the light
line. Identical results were obtained with P-selectin–Ig
stained in the presence of EDTA (not depicted). Num-
bers indicate the percentage of positively stained cells
on the basis of control Ab staining. (B) Results of  4 7
and functional PSGL-1 expression on DO11.10 cells
from pooled peripheral LN (PLN; brachial, axillary,
and inguinal) taken from mice 3 d after i.p. OVA/CFA
challenge, and stained with anti- 4 7 and P-selectin–
Ig (Materials and Methods). Cells were gated on the
basis of CD4 and KJ1–26.1 staining and numbers indi-
cate the percentage of positively stained cells based on
control Ab staining. (C) Results of  4 7 and func-
tional PSGL-1 expression on MLN DO11.10 cells iso-
lated from mice 2 d after i.p. OVA323–339 and LPS
(OVA/LPS) challenge are shown. Cells were stained
with anti- 4 7 and P-selectin–Ig (Materials and Meth-
ods) and gated on the basis of CD4 and KJ1–26.1 stain-
ing. Numbers indicate the percentage of positively
stained cells based on control Ab staining. Data are
representative of three independent experiments with
similar results.T
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released at the time of activation of naive T cells within
MLN promotes Th1 functional differentiation and en-
hances functional PSGL-1 expression on cells that reenter
the circulation. Binding of PSGL-1 to P-selectin slows the
transit of activated cells through mucosal blood vessels and
allows cells to sample endothelial surfaces for activating fac-
tors such as chemokines (24). These events enable the re-
cruitment of appropriate Ag-specific populations of Th1
cells to the intestine where they deliver effector immune
responses. It should be noted that data in Fig. 4 suggest that
recruitment under these conditions need not require that
Ag be present in the tissue. This allows memory T cells to
seed distant sites within a host before reexposure to a mu-
cosal pathogen.
The current data suggest that P-selectin rather than
E-selectin mediates recruitment of activated T cells to the in-
testine under noninflamed conditions. Data from Granger
and colleagues indicate that P-selectin, but not E-selectin,
is expressed constitutively on endothelial cells throughout
the intestine (23). Both may be induced with endotoxin
and/or cytokine (TNF). Although enhanced P-selectin
expression is long-lived (lasting several days), increased
E-selectin expression tends to be short-lived ( 8 h; refer-
ence 25). Blockade of P-selectin, but not E-selectin, re-
Figure 3. P-Selectin binding is essential for optimal recruitment of activated T cells to
LP. BALB/c mice, adoptively transferred with CD4  KJ1.26  T cells, were treated with
control mAb (C mAb) or anti–P-selectin in addition to Ag challenge. Mice were killed
and analyzed 7 d after Ag challenge. (A) Cells from spleen, MLN, LP, and PP were iso-
lated at 7 d and stained with KJ1–26.1–PE, anti–CD4 mAb-FITC, and anti–Thy-1 APC
(for gating). Numbers on top right quadrant represent the percentages of CD4  KJ1–26.1 
cells out of total CD4  T cells in each compartment. (B) Yields (mean   SEM) of the
transferred CD4  KJ1.26  cells recovered in SP, MLN, PP, and LP from each indicated group (n   3/group) at 7 d. (C) Comparison of percentage
change induced by anti–P-selectin mAb treatment of CD4  KJ1–26.1  cell yields (mean   SEM) relative to Ag-challenged, control mAb-treated con-
trols (n   3). *, P   0.05; **, P   0.0001.T
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duces leukocyte rolling in states of ischemia/reperfusion
(26), experimental colitis (27, 28), and radiation injury
(29). Taken with our own, these data suggest that func-
tional PSGL-1 and P-selectin play a greater role in recruit-
ment of effector T cells to the intestine compared with
E-selectin ligand and E-selectin.
A possibility not addressed in these previous works was
whether PSGL-1 could bind E-selectin. Using PSGL-1 / 
mice, McEvers and colleagues found that PSGL-1 may play
a novel role in tethering leukocytes to E-selectin under
flow (30). To address this issue, we examined the effect of
E-selectin on recruitment of activated T cells to the intesti-
nal LP. We found that blockade of P-selectin (Fig. 3), but
not E-selectin (Fig. S1), reduced recruitment of activated
DO11.10 T cells to the intestinal LP. Thus, these data are
consistent with the notion that E-selectin does not play a
major role in recruitment of activated Th1 cells to the LP
in noninflamed mice and that PSGL-1 is not the major
ligand for E-selectin. However, it remains possible that
during states of intestinal inflammation (infectious or re-
gional enteritis, ischemia, sepsis, etc.), E-selectin may in-
crease in the intestine. Under these conditions, E-selectin
may bind functional PSGL-1 or E-selectin ligand expressed
by Th1 cells, thus, increasing intestinal recruitment of these
effector T cell subsets.
The data presented suggest that T cells required a rela-
tively prolonged period of activation and differentiation
before recruitment to the intestine occurs. In previous
studies by Iezzi et al. (31), it was suggested that nonpolar-
ized cells generated by a short (24-h) antigenic stimulation
are intermediate between naive and effector cells and mi-
grate to peripheral lymphoid but not nonlymphoid tissue.
In contrast, cells activated with Ag for longer periods (96 h)
in the presence of differentiating cytokine become mem-
ory-like effector cells that preferentially migrate to non-
lymphoid compared with lymphoid tissue. These findings
suggest that the pattern of distribution of activated cells to
peripheral tissue may change within relatively short periods
of time. In the model presented here, DO11.10 T cells
were activated with i.p. Ag in CFA. The use of CFA al-
lows Ag to persist while inducing local IL-12 production
by APC (32, 33), thus, promoting functional PSGL-1 and
recruitment to the intestinal LP. Studies by Campbell et al.
examined expression of homing receptors on DO11.10 T
Figure 4. Blocking of recruitment of Th1 cells to LP by anti–P-selectin
and anti-MAdCAM. In vitro differentiated Th1 or Th2 cells were injected
i.v. into BALB/c mice pretreated with control, anti–P-selectin, or anti-
MAdCAM mAbs. At 72 h, SP, MLN, PP, and LP cells were isolated from
the mice. (A) Cells were stained with KJ1–26.1–PE, anti–CD4 mAb-
FITC, and anti–Thy-1 APC (for gating). Numbers on top right quadrants
represent the percentages of CD4  KJ1–26.1  cells out of total CD4  T
cells in each compartment. (B) Comparison of percentage changes in Th1
DO11.10 cells induced by anti–P-selectin and anti-MAdCAM mAb treat-
ments. Results show the mean   SEM of the percent change in CD4 
KJ1–26.1  cell yields relative to control mAb–treated mice in parallel exper-
iments. *, P   0.02; **, P   0.008, n   3. Results show that anti-MAdCAM
mAb reduced Th1 recruitment to PP and LP, whereas anti–P-selectin re-
duced Th1 recruitment to the intestinal LP with relatively minor effects on
PP Th1 recruitment. (C) Absolute yields of Th1 and Th2 cells recovered in
SP, MLN, PP, and LP 3 d after the adoptive cell transfer. Data show that
Th1, but not Th2, cells were recruited to the LP in relatively high num-
bers. One representative experiment out of three is shown.T
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cells after a limited, 48-h period of activation with OVA
protein and LPS (17). These data suggested that short-term
Ag priming with LPS and OVA protein generates distinct
T cell subsets expressing either  4 7 or functional PSGL-1,
but not both. In contrast, we found that a distinct subset
of MLN DO11.10 T cells in adoptive transfer mice given
i.p. LPS plus OVA323–339 peptide express both  4 7 and
functional PSGL-1 (Fig. 2 C). It is possible that repeated
stimulation of cells with Ag and LPS (beyond 48 h) may
have induced even greater numbers of cells coexpressing
both  4 7 and functional PSGL-1. Together with data in
OVA/CFA–treated mice, we suspect that prolonged peri-
ods of activation with Ag and differentiating cytokine (IL-
12) generates populations of activated T cells analogous to
the memory-like, effector cells described by Lanzavecchia
and colleagues (31). Thus, the data presented fit with the
emerging paradigm that selectin ligands mediate the re-
cruitment of differentiated, memory-like effector cells to
nonlymphoid compartments in tissue like the LP.
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